AI drug discovery - USA Herald

Home
Authors

America February 23, 2026

Generate Biomedicines Files for $400 Million IPO to Advance Long-Acting Antibody Candidate for Severe Asthma Unmet Need

Generate Biomedicines, a Massachusetts-based biotech leveraging an AI-powered discovery platform to “program biology” for breakthrough therapeutics, filed Monday with U.S.…

By Rachel Moore

America October 2, 2025

Nanyang Biologics To Go Public in $1.5B SPAC Deal

Singapore-based Nanyang Biologics Pte. Ltd. revealed Thursday it will go public in the U.S. via a merger with special purpose…

By Rihem Akkouche

FOLLOW US

Generate Biomedicines Files for $400 Million IPO to Advance Long-Acting Antibody Candidate for Severe Asthma Unmet Need

Nanyang Biologics To Go Public in $1.5B SPAC Deal

Recent Posts

Kelly Warner Law Firm Blames USA Herald for Arizona Bar Investigation

Aaron Kelly Law Firm Resorts To Attacking Former Client Again On KellyWarnerLaw.com – Pattern Recognized

Arizona Bar Opens Investigation on Attorney Aaron Kelly

A Violent July 4 Attack Leads To Federal Convictions For Nine Antifa Cell Members Convicted In Prairieland ICE Detention Center Shooting

Trump UFO Directive Could Shake Religion Science And Power Structures Worldwide

Ancient Astronomers Warned That Strange Skies Precede Global Upheaval—Why Their Writings Are Being Revisited Today

Oil, War, and the Insurance Shockwave Already Hitting America

US Navy Prepares To Escort Tankers Through Strait of Hormuz As Oil War Risks Escalate

FOLLOW US

Recent Posts

Signup for the USA Herald exclusive Newsletter

Signup for the USA Herald
exclusive Newsletter